Thanks again doubleJ23. I agree that they are conc
Post# of 72444
Posted On: 12/16/2015 11:20:11 AM
Thanks again doubleJ23. I agree that they are concerned about NOT repeating the PolyMedix mistakes that PYMX did with their other drug candidate, having side effects that prevented approval. I think that it's wise to start with the smallest effective dose to get approval, even if it means that it may be effective for a smaller percentage of patients. Doctors can always give a larger dose to a very heavy patient (assuming it's dependent on body weight), or a second dose, if necessary.
We speculated at the beginning of the Kevetrin trial that they were starting with such small doses for the same reason -- completely new type of drug, wanting to be sure they didn't harm patients with an untested drug. Safety seems paramount to CTIX.
I certainly appreciate your very specific summary of your impressions of the meeting.
We speculated at the beginning of the Kevetrin trial that they were starting with such small doses for the same reason -- completely new type of drug, wanting to be sure they didn't harm patients with an untested drug. Safety seems paramount to CTIX.
I certainly appreciate your very specific summary of your impressions of the meeting.
(0)
(0)